Dindo Sy Chu

Vice President Finance at Sorrento Therapeutics

Dindo Sy Chu is a seasoned finance executive with extensive experience in financial planning, analysis, and management across various industries. Dindo currently serves as Vice President of Finance at Sorrento Therapeutics, Inc., focusing on commercial and R&D finance since October 2015. Previously, Dindo held the position of Vice President of Finance at Scilex Pharmaceuticals and served as Chief Finance Officer at Rustan Supercenters under The Dairy Farm Group. Dindo's career includes key roles at Avon and Roche Pharmaceuticals, where responsibilities spanned commercial finance, treasury management, and internal audit in multiple countries, including China, Hong Kong, Indonesia, and Korea. Dindo holds a Master's degree in Computer Applications and a Bachelor's degree in Business and Economics with a major in Accounting from De La Salle University.

Location

San Diego, United States

Links

Previous companies


Org chart


Teams


Offices


Sorrento Therapeutics

3 followers

Sorrento Therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases.


Industries

Employees

51-200

Links